CryoPort/$CYRX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About CryoPort

CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.

Ticker

$CYRX
Primary listing

Industry

Life Sciences Tools & Services

Employees

1,098

ISIN

US2290503075

CryoPort Metrics

BasicAdvanced
$376M
-
-$2.34
1.92
-

What the Analysts think about CryoPort

Analyst ratings (Buy, Hold, Sell) for CryoPort stock.

Bulls say / Bears say

Cryoport's Life Sciences Services revenue increased by 17.3% year-over-year in Q1 2025, indicating strong growth in this segment. (aijourn.com)
The company supported 701 global clinical trials as of December 31, 2024, up from 675 the previous year, reflecting its expanding role in the biopharmaceutical industry. (ir.cryoportinc.com)
Cryoport held $261.7 million in cash, cash equivalents, and short-term investments as of December 31, 2024, providing a strong liquidity position to support future growth initiatives. (marketscreener.com)
Cryoport reported a net loss of $114.8 million for FY 2024, an increase from $99.6 million in the previous year, indicating ongoing profitability challenges. (marketscreener.com)
The Life Sciences Products segment experienced a revenue decline of 16.2% in FY 2024 compared to the previous year, suggesting potential issues in product demand or market competition. (ir.cryoportinc.com)
Cryoport's adjusted EBITDA was negative $15.1 million for FY 2024, compared to negative $8.3 million in FY 2023, reflecting deteriorating operational profitability. (marketscreener.com)
Data summarised monthly by Lightyear AI. Last updated on 8 Jul 2025.

CryoPort Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

CryoPort Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $CYRX

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs